Could prozac or DHEA protect against dangerous low blood sugar in diabetes?

NCT ID NCT03228732

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-phase study is testing whether the antidepressant fluoxetine (Prozac) and/or the hormone DHEA can improve the body's ability to defend against low blood sugar in people with type 1 diabetes. About 60 adults will take the drugs or a placebo for 8 weeks, then undergo two-day hospital visits where their responses to low blood sugar are measured. The goal is to understand how these substances affect stress hormones and metabolism, not to treat diabetes itself.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Fluoxetine (Prozac) and/or DHEA (dehydroepiandrosterone)
What this could lead to
If it works, this could point toward a way to help people with type 1 diabetes better recognize and respond to low blood sugar, reducing dangerous episodes.
What could go wrong
This is a very early, small study (60 people) testing body responses, not a treatment. The high DHEA dose may have unknown side effects, and results may not lead to a practical therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Maryland

    RECRUITING

    Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.